Expert Review of Clinical Pharmacology

Expert Review of Clinical Pharmacology 由 Taylor and Francis Ltd. 出版，属中科院医学大类（2025 升级版3区）。按 OpenAlex 近年发文统计，该刊主要发表 Diabetes Treatment and Management、Health Systems, Economic Evaluations, Quality of Life、Pharmaceutical studies and practices 等主题的论文，这 3 个主题约占 21.3%。（根据 OpenAlex 主题统计与中科院分区数据生成）

Advances in drug development technologies are yielding innovative new therapies, from potentially lifesaving medicines to lifestyle products. In recent years, however, the cost of developing new drugs has soared, and concerns over drug resistance and pharmacoeconomics have come to the fore. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery. Clinical Pharmacology provides an essential role in integrating the expertise of all of the specialists and players who are active in meeting such challenges in modern biomedical practice.

来源：LetPub

研究方向（LetPub）：PHARMACOLOGY & PHARMACY

中科院期刊分区表

数据库收录

SCIEScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

3.8LetPub · 2026-09-13

CiteScore 2026-06

5.9LetPub · 2026-09-13

SJR 2026-06

0.85LetPub · 2026-09-13

SNIP 2026-06

0.95LetPub · 2026-09-13

h-index

32LetPub · 2026-09-13

h-index

83OpenAlex · 2026-10-01

i10-index

1,036OpenAlex · 2026-10-01

两年平均被引

3.49OpenAlex · 2026-10-01

自引率

0%LetPub · 2026-09-13

Gold OA 文章占比

4.09%LetPub · 2026-09-13

发文规模

年文章数

84LetPub · 2026-09-13

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

尚未从任何来源获得费用信息，请以期刊官网为准。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

出版商

Taylor and Francis Ltd.

出版国家或地区

ENGLAND

出版语言

English

ISSN

1751-2433

电子版 ISSN

1751-2441

官方链接

• 期刊主页 ↗OpenAlex
• 投稿系统 ↗LetPub